Results
2
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
2 companies
OSE Immunotherapeutics
Market Cap: €123.6m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€5.65
7D
-1.7%
1Y
-5.4%
Genfit
Market Cap: €152.8m
A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.
GNFT
€3.06
7D
-3.6%
1Y
-5.3%